The balance of risks and benefits of drug-eluting versus bare-metal stents

J Am Coll Cardiol. 2008 Mar 4;51(9):972; author reply 972-3. doi: 10.1016/j.jacc.2007.08.070.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Coronary Thrombosis / etiology*
  • Drug-Eluting Stents / adverse effects
  • Humans
  • Myocardial Infarction / etiology*
  • Risk Assessment
  • Stents / adverse effects*
  • Time Factors